Negative regulation of bcl-2 expression by p53 in hematopoietic cells (Q40811024)

23 September 2017

title

Negative regulation of bcl-2 expression by p53 in hematopoietic cells (English)

1 reference

23 September 2017

Wu Y

1 reference

23 September 2017

Mehew JW

1 reference

23 September 2017

Heckman CA

1 reference

23 September 2017

Arcinas M

1 reference

23 September 2017

Boxer LM

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

240-251

1 reference

Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Wild-type p53 can down-modulate the activity of various promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Histone deacetylase activity is required for full transcriptional repression by mSin3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Rb interacts with histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

The polyproline region of p53 is required to activate apoptosis but not growth arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Wild-type p53 binds to the TATA-binding protein and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Negative regulation of Rb expression by the p53 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

p53 expression in lymphatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Identification of a novel p53 functional domain that is necessary for efficient growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Overexpression of the MDM2 oncogene in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

Heterogeneity in cell proliferation and expression of p53 and bcl-2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

p53 in growth control and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

P53 protein expression in lymphomas and reactive lymphoid tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204067

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204067

1 reference

Dimensions Publication ID

23 September 2017

1033615667

0 references

1 reference